Fidelta

Ardigen is harnessing advanced Artificial Intelligence methods for novel precision medicine. The company accelerates therapy development by designing immunity, decoding microbiome, analyzing biomedical images and providing digital drug discovery services. Ardigen's team is rooted in biology and holds deep expertise in bioinformatics, machine learning, and software engineering. The company's in-house datasets together with advanced AI platforms empower the development of effective precision therapies.